The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Current Epidemiology and Growing Resistance of Gram-Negative Pathogens
Open accessAbstract
In the 1980s, gram-negative pathogens appeared to have been beaten by oxyimino-cephalosporins, carbapenems, and fluoroquinolones. Yet these pathogens have fought back, aided by their membrane organization, which promotes the exclusion and efflux of antibiotics, and by a remarkable propensity to recruit, transfer, and modify the expression of resistance genes, including those for extended-spectrum β-lactamases (ESBLs), carbapenemases, aminoglycoside-blocking 16S rRNA methylases, and even a quinolone-modifying variant of an aminoglycoside-modifying enzyme. Gram-negative isolates--both fermenters and non-fermenters--susceptible only to colistin and, more variably, fosfomycin and tigecycline, are encountered with increasing frequency, including in Korea. Some ESBLs and carbapenemases have become associated with strains that have great epidemic potential, spreading across countries and continents; examples include Escherichia coli sequence type (ST)131 with CTX-M-15 ESBL and Klebsiella pneumoniae ST258 with KPC carbapenemases. Both of these high-risk lineages have reached Korea. In other cases, notably New Delhi Metallo carbapenemase, the relevant gene is carried by promiscuous plasmids that readily transfer among strains and species. Unless antibiotic stewardship is reinforced, microbiological diagnosis accelerated, and antibiotic development reinvigorated, there is a real prospect that the antibiotic revolution of the 20th century will crumble.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Self-citationDrugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512 · cited 1×
“The reasons are threefold: first, the technical difficulty of discovering new antibiotics, especially those able to penetrate Gram-negative bacteria [3,4]; second, the regulatory hurdles to new antibiotics which have become increasingly complex [5]; and, third, the brutal fact that antibiotics, as short-course treatme…”
BackgroundJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Self-citationPseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Self-citationCarbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Self-citationWoodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Self-citationResistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii
Fournier, P.-E., Vallenet, D., Barbe, V., Audic, S., Ogata, H., Poirel, L., Richet, H., Robert, C., Mangenot, S., Abergel, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020007 · Cited by 812
The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii
Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., & Pitt, T. L. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00195.x · Cited by 751
Self-citationPaul, M., Shani, V., Muchtar, E., Kariv, G., Robenshtok, E., & Leibovici, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00627-10 · Cited by 724
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Unemo, M., Golparian, D., Nicholas, R., Ohnishi, M., Gallay, A., & Sednaoui, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05760-11 · Cited by 653
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Metallo-β-lactamases: a last frontier for β-lactams?
Cornaglia, G., Giamarellou, H., & Rossolini, G. M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70056-1 · Cited by 613
Resistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
The spread of CTX-M-type extended-spectrum β-lactamases
Rossolini, G. M., D'Andrea, M. M., & Mugnaioli, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01867.x · Cited by 487
Doumith, M., Ellington, M. J., Livermore, D. M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp029 · Cited by 450
Self-citationComparative Genome Sequence Analysis of Multidrug-Resistant Acinetobacter baumannii
Adams, M. D., Goglin, K., Molyneaux, N., Hujer, K. M., Lavender, H., Jamison, J. J., MacDonald, I. J., Martin, K. M., Russo, T., Campagnari, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.00834-08 · Cited by 435
Boyd, D. A., Tyler, S., Christianson, S., McGeer, A., Muller, M. P., Willey, B. M., Bryce, E., Gardam, M., Nordmann, P., & Mulvey, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3758-3764.2004 · Cited by 389
Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Self-citationTängdén, T., Cars, O., Melhus, A., & Löwdin, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00220-10 · Cited by 372
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Pagès, J.-M., & Amaral, L. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.011 · Cited by 329
Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Prevalence and clonality of extended-spectrum β-lactamases in Asia
Hawkey, P. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01855.x · Cited by 289
Discovery research: the scientific challenge of finding new antibiotics
Livermore, D. M., on behalf of the British Society for Antimicrobial Chemotherapy Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development, Blaser, M., Carrs, O., Cassell, G., Fishman, N., Guidos, R., Levy, S., Powers, J., Norrby, R., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr262 · Cited by 284
Self-citationWoodford, N., Carattoli, A., Karisik, E., Underwood, A., Ellington, M. J., & Livermore, D. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00688-09 · Cited by 283
Self-citationSpread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
UK national guideline for the management of gonorrhoea in adults, 2011
Bignell, C., FitzGerald, M., & (Guideline Development Group) (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011267 · Cited by 270
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Livermore, D. M., Mushtaq, S., Warner, M., Zhang, J., Maharjan, S., Doumith, M., & Woodford, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-10 · Cited by 261
Self-citationBoron-containing inhibitors of synthetases
Baker, S. J., Tomsho, J. W., & Benkovic, S. J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00131g · Cited by 256
Kollef, M. H. (2008) · Clinical Infectious Diseases · doi:10.1086/590061 · Cited by 248
The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones
Naseer, U., & Sundsfjord, A. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0132 · Cited by 236
Livermore, D. M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.012 · Cited by 232
Self-citationClinical significance of beta-lactamase induction and stable derepression in gram-negative rods
Livermore, D. M. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02013107 · Cited by 210
Self-citationAcinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp
Poirel, L., Figueiredo, S., Cattoir, V., Carattoli, A., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01304-07 · Cited by 205
Rooney, P. J., O'Leary, M. C., Loughrey, A. C., McCalmont, M., Smyth, B., Donaghy, P., Badri, M., Woodford, N., Karisik, E., & Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp220 · Cited by 198
Self-citationEXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMS
Jacoby, G. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70395-0 · Cited by 184
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp
Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., & Carmeli, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2628-2630.2001 · Cited by 181
Trends among pathogens reported as causing bacteraemia in England, 2004–2008
Wilson, J., Elgohari, S., Livermore, D. M., Cookson, B., Johnson, A., Lamagni, T., Chronias, A., & Sheridan, E. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03262.x · Cited by 174
Self-citationCephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
Chisholm, S. A., Mouton, J. W., Lewis, D. A., Nichols, T., Ison, C. A., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq289 · Cited by 174
Self-citationLascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
García-Fernández, A., Miriagou, V., Papagiannitsis, C. C., Giordano, A., Venditti, M., Mancini, C., & Carattoli, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01301-09 · Cited by 158
Rodríguez‐Baño, J., Picón, E., Gijón, P., Hernández, J. R., Cisneros, J. M., Peña, C., Almela, M., Almirante, B., Grill, F., Colomina, J., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02353-09 · Cited by 157
Crespo, M., Woodford, N., Sinclair, A., Kaufmann, M. E., Turton, J. F., Glover, J., Vélez, J. D., Castañeda-Ramirez, C. R., Recalde, M. P., & Livermore, D. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5094-5101.2004 · Cited by 153
Self-citationKarisik, E., Ellington, M. J., Pike, R., Warren, R. E., Livermore, D. M., & Woodford, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl309 · Cited by 151
Self-citationExtended-spectrum β-lactamases in North America, 1987–2006
Bush, K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01848.x · Cited by 150
Dierkes, C., Ehrenstein, B. P., Siebig, S., Linde, H., Reischl, U., & Salzberger, B. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-126 · Cited by 149
Elliott, E., Brink, A. J., van Greune, J., Els, Z., Woodford, N., Turton, J. F., Warner, M., & Livermore, D. M. (2006) · Clinical Infectious Diseases · doi:10.1086/503264 · Cited by 147
Self-citationAdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Hornsey, M., Ellington, M. J., Doumith, M., Thomas, C. P., Gordon, N. C., Wareham, D. W., Quinn, J. P., Lolans, K., Livermore, D. M., & Woodford, N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq218 · Cited by 146
Self-citationImpact of Clinical Guidelines in the Management of Severe Hospital-Acquired Pneumonia
Hoo, G. W. S., Wen, Y., Nguyen, T. V., & Goetz, M. B. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2778 · Cited by 143
Fritsche, T. R., Castanheira, M., Miller, G. H., Jones, R. N., & Armstrong, E. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-07 · Cited by 143
Xiao, X.-Y., Hunt, D. K., Zhou, J., Clark, R. B., Dunwoody, N., Fyfe, C., Grossman, T. H., O’Brien, W. J., Plamondon, L., Rönn, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201465w · Cited by 126
The intrinsic resistome ofPseudomonas aeruginosato β-lactams
Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Hancock, R. E. W., & Martínez, J. L. (2011) · Virulence · doi:10.4161/viru.2.2.15014 · Cited by 123
Sader, H. S., Rhomberg, P. R., Farrell, D. J., & Jones, R. N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01737-10 · Cited by 123
Jeong, S. H., Bae, I. K., Lee, J. H., Sohn, S. G., Kang, G. H., Jeon, G. J., Kim, Y. H., Jeong, B. C., & Lee, S. H. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.2902-2906.2004 · Cited by 123
Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary
Tóth, Á., Damjanova, I., Puskás, E., Jánvári, L., Farkas, M., Dobák, A., Böröcz, K., & Pászti, J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-0921-3 · Cited by 119
Bertrand, X., & Dowzicky, M. J. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.023 · Cited by 118
Partridge, S. R., Zong, Z., & Iredell, J. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00025-11 · Cited by 118
Multilocus sequence typing of IncN plasmids
García-Fernández, A., Villa, L., Moodley, A., Hasman, H., Miriagou, V., Guardabassi, L., & Carattoli, A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr225 · Cited by 118
Combating evolution with intelligent design: the neoglycoside ACHN-490
Armstrong, E. S., & Miller, G. H. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.004 · Cited by 107
Hsueh, P., Badal, R. E., Hawser, S., Hoban, D. J., Bouchillon, S. K., Ni, Y., & Paterson, D. L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.07.002 · Cited by 92
Shim, B. S., Kim, C. S., Kim, M. E., Lee, S.-J., Lee, D. S., Choe, H., & Cho, Y. H. (2010) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0178-x · Cited by 77
Optimizing Antimicrobial Therapy in Sepsis and Septic Shock
Kumar, A. (2009) · Critical Care Clinics · doi:10.1016/j.ccc.2009.08.004 · Cited by 76
Park, S. H., Choi, S., Lee, D., Kim, J., Choi, J., Kim, S., Kwon, J., & Yoo, J. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0072 · Cited by 75
Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00061-09 · Cited by 70
Lee, M., Choi, H. J., Choi, J. Y., Song, M., Song, Y., Kim, S., Chang, H., Jung, S.-I., Ys, K., Ki, H. K., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.11.004 · Cited by 69
Effective antibacterials: at what cost? The economics of antibacterial resistance and its control
White, A. R., Development, O. B. O. T. B. W. P. O. T. U. N. R. A. D. D. A., Blaser, M. J., Carrs, O., Cassell, G. H., Fishman, N. O., Guidos, R., Levy, S. B., Powers, J. H., Norrby, R. S., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr260 · Cited by 69
Self-citationRhee, J.-Y., Park, Y. K., Shin, J. Y., Choi, J. Y., Lee, M. Y., Peck, K. R., Song, J., & Ko, K. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00011-10 · Cited by 67
Vince, A., Lepej, S. Ž., Baršić, B., Dušek, D., Mitrović, Z., Serventi-Seiwerth, R., & Labar, B. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47797-0 · Cited by 59 · cited 1×
“Potential methods exist, including polymerase chain reaction or DNA arrays to seek species- and resistance-specific genes [129,130].”
MethodShin, J., Kim, D. H., & Ko, K. S. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.003 · Cited by 58
Kim, M. E., Ha, U., & Cho, Y. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.043 · Cited by 58
Lee, D. S., Lee, C. B., & Lee, S.-J. (2010) · Korean journal of urology · doi:10.4111/kju.2010.51.7.492 · Cited by 58
Dhanji, H., Doumith, M., Rooney, P. J., O'Leary, M. C., Loughrey, A. C., Hope, R., Woodford, N., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq463 · Cited by 57
Self-citationChandel, D. S., Johnson, J. A., Chaudhry, R., Sharma, N., Shinkre, N., Parida, S., Misra, P. R., & Panigrahi, P. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.027375-0 · Cited by 57
Ho, P., Yip, K.-S., Chow, K., Lo, J. Y. C., Que, T., & Yuen, K. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.03.027 · Cited by 56
Seok, Y., Bae, I. K., Jeong, S. H., Kim, S. H., Lee, H., & Lee, K. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr381 · Cited by 56
Suh, B., Bae, I. K., Kim, J., Jeong, S. H., Yong, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00768-10 · Cited by 55
The new treatment paradigm and the role of carbapenems
Masterton, R. G. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.07.023 · Cited by 49
Schwaber, M. J., Graham, C. S., Sands, B. E., Gold, H. S., & Carmeli, Y. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1882-1886.2003 · Cited by 48
Jeong, S. H., Bae, I. K., Kwon, S. B., Lee, J. H., Song, J., Jung, H. I., Sung, K. H., Jang, S., & Lee, S. H. (2005) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2004.02526.x · Cited by 45
Blood culture systems: rapid detection – how and why?
Gaibani, P., Rossini, G., Ambretti, S., Gelsomino, F., Pierro, A. M., Varani, S., Paolucci, M., Landini, M. P., & Sambri, V. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70559-x · Cited by 39
Lee, H. K., Park, Y.-J., Kim, J., Chang, E.-D., Cho, S., Chae, H. S., & Kang, C. S. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.04.012 · Cited by 31
Roh, K. H., Lee, C. K., Sohn, J. W., Song, W., Yong, D., & Lee, K. (2011) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2011.31.4.298 · Cited by 26
The rise of antimicrobial resistance: a clear and present danger
Holmes, N. E., & Howden, B. P. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.49 · Cited by 10
Cited by
Llor, C., & Bjerrum, L. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614554919 · Cited by 2,079
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Adeolu, M., Alnajar, S., Naushad, S., & S. Gupta, R. (2016) · International Journal of Systematic and Evolutionary Microbiology · doi:10.1099/ijsem.0.001485 · Cited by 998
Mechanisms of inflammation-driven bacterial dysbiosis in the gut
Zeng, M. Y., Inohara, N., & Nuñez, G. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.75 · Cited by 877
Metadata
- Authors
- Livermore, D. M.
- Venue
- The Korean Journal of Internal Medicine
- Published
- 2012
- Volume
- 27
- Issue
- 2
- Pages
- 128
- ISSN
- 1226-3303 (ISSN-L)
- 2005-6648
- OpenAlex
- W2127253161
- Cited by
- 417
- References
- 98
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.